Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic factors for survival with nab-paclitaxel plus gemcitabine in metastatic pancreatic cancer in real-life practice: the ANICE-PaC study.
Fernández A, Salgado M, García A, Buxò E, Vera R, Adeva J, Jiménez-Fonseca P, Quintero G, Llorca C, Cañabate M, López LJ, Muñoz A, Ramírez P, González P, López C, Reboredo M, Gallardo E, Sanchez-Cánovas M, Gallego J, Guillén C, Ruiz-Miravet N, Navarro-Pérez V, De la Cámara J, Alés-Díaz I, Pazo-Cid RA, Carmona-Bayonas A. Fernández A, et al. Among authors: lopez lj. BMC Cancer. 2018 Nov 29;18(1):1185. doi: 10.1186/s12885-018-5101-3. BMC Cancer. 2018. PMID: 30497432 Free PMC article.
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial.
Rivera F, Izquierdo-Manuel M, García-Alfonso P, Martínez de Castro E, Gallego J, Limón ML, Alsina M, López L, Galán M, Falcó E, Manzano JL, González E, Muñoz-Unceta N, López C, Aranda E, Fernández E, Jorge M, Jiménez-Fonseca P. Rivera F, et al. Eur J Cancer. 2021 Mar;145:158-167. doi: 10.1016/j.ejca.2020.12.005. Epub 2021 Jan 20. Eur J Cancer. 2021. PMID: 33485079 Clinical Trial.
Cetuximab given every 2 weeks plus irinotecan is an active and safe option for previously treated patients with metastatic colorectal cancer.
Roca JM, Alonso V, Pericay C, Escudero P, Salud A, Losa F, López LJ, Guasch I, Méndez M, Quintero-Aldana G, Grande C, Vicente P, Arrivi A, Martin C, Moreno I, García P, Antón I, Constenla M, Yubero A, Cirera L; ACROSS Cooperative Group. Roca JM, et al. Among authors: lopez lj. Chemotherapy. 2010;56(2):142-6. doi: 10.1159/000313527. Epub 2010 Apr 21. Chemotherapy. 2010. PMID: 20407241 Clinical Trial.
Skin cancer prevention in extreme sports: Intervention in a 24-h race.
Martínez AR, Pardal CV, Arjona JA, Ruiz FR, Molinero DD, Paulano MR, Subert A, Manzanedo JVG, Cambil Martín J, de Gálvez Aranda MV, López LJ, Sánchez NB, de Troya Martín M. Martínez AR, et al. Among authors: lopez lj. Photodermatol Photoimmunol Photomed. 2024 Jan;40(1):e12940. doi: 10.1111/phpp.12940. Photodermatol Photoimmunol Photomed. 2024. PMID: 38288775
Improving Information Extraction from Pathology Reports using Named Entity Recognition.
Zeng KG, Dutt T, Witowski J, Kranthi Kiran GV, Yeung F, Kim M, Kim J, Pleasure M, Moczulski C, Lopez LJL, Zhang H, Harbi MA, Shamout FE, Major VJ, Heacock L, Moy L, Schnabel F, Pak LM, Shen Y, Geras KJ. Zeng KG, et al. Among authors: lopez ljl. Res Sq [Preprint]. 2023 Jul 3:rs.3.rs-3035772. doi: 10.21203/rs.3.rs-3035772/v1. Res Sq. 2023. PMID: 37461545 Free PMC article. Preprint.
22 results